Successful treatment of refactory mucosal lesions of pemphigus vulgaris using intravenous gammaglobulin as adjuvant therapy.
- 1 November 1996
- journal article
- Published by Wiley in British Journal of Dermatology
- Vol. 135 (5) , 862-863
- https://doi.org/10.1111/j.1365-2133.1996.tb03913.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgarisBritish Journal of Dermatology, 1995
- Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patientsBritish Journal of Dermatology, 1995
- A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for DermatomyositisNew England Journal of Medicine, 1993
- Manipulating the Immune System with Immune GlobulinNew England Journal of Medicine, 1992
- Effects of intravenous γ-globulin in pemphigusJournal of the American Academy of Dermatology, 1990
- High-dosage intravenous gamma globulin: Therapeutic failure in pemphigus and pemphigoidJournal of the American Academy of Dermatology, 1989
- Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigusBritish Journal of Dermatology, 1988